International consensus on allergen immunotherapy II: mechanisms, standardization, and pharmacoeconomics
This article continues the comprehensive international consensus (ICON) statement on allergen immunotherapy (AIT). The initial article also recently appeared in the Journal. The conclusions below focus on key mechanisms of AIT-triggered tolerance, requirements in allergen standardization, AIT cost-e...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
February 2016
|
| In: |
The journal of allergy and clinical immunology
Year: 2016, Jahrgang: 137, Heft: 2, Pages: 358-368 |
| ISSN: | 1097-6825 |
| DOI: | 10.1016/j.jaci.2015.12.1300 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1016/j.jaci.2015.12.1300 Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0091674915031140 
|
| Verfasserangaben: | Marek Jutel, MD, Ioana Agache, MD, Sergio Bonini, MD, A. Wesley Burks, MD, Moises Calderon, MD, Walter Canonica, MD, Linda Cox, MD, Pascal Demoly, MD, Antony J. Frew, MD, FRCP, Robyn O’Hehir, FRACP, PhD, Jörg Kleine-Tebbe, MD, Antonella Muraro, MD, PhD, Gideon Lack, MD, Désirée Larenas, MD, Michael Levin, MD, Bryan L. Martin, MD, Harald Nelson, MD, Ruby Pawankar, MD, Oliver Pfaar, MD, Ronald van Ree, PhD, Hugh Sampson, MD, James L. Sublett, MD, Kazunari Sugita, MD, George Du Toit, MD, Thomas Werfel, MD, Roy Gerth van Wijk, MD, Luo Zhang, MD, Mübeccel Akdis, MD, and Cezmi A. Akdis, MD |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1586719149 | ||
| 003 | DE-627 | ||
| 005 | 20230427034220.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190129s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jaci.2015.12.1300 |2 doi | |
| 035 | |a (DE-627)1586719149 | ||
| 035 | |a (DE-576)516719149 | ||
| 035 | |a (DE-599)BSZ516719149 | ||
| 035 | |a (OCoLC)1341034494 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Jutel, Marek |d 1964- |e VerfasserIn |0 (DE-588)1153576996 |0 (DE-627)101508737X |0 (DE-576)500326746 |4 aut | |
| 245 | 1 | 0 | |a International consensus on allergen immunotherapy II |b mechanisms, standardization, and pharmacoeconomics |c Marek Jutel, MD, Ioana Agache, MD, Sergio Bonini, MD, A. Wesley Burks, MD, Moises Calderon, MD, Walter Canonica, MD, Linda Cox, MD, Pascal Demoly, MD, Antony J. Frew, MD, FRCP, Robyn O’Hehir, FRACP, PhD, Jörg Kleine-Tebbe, MD, Antonella Muraro, MD, PhD, Gideon Lack, MD, Désirée Larenas, MD, Michael Levin, MD, Bryan L. Martin, MD, Harald Nelson, MD, Ruby Pawankar, MD, Oliver Pfaar, MD, Ronald van Ree, PhD, Hugh Sampson, MD, James L. Sublett, MD, Kazunari Sugita, MD, George Du Toit, MD, Thomas Werfel, MD, Roy Gerth van Wijk, MD, Luo Zhang, MD, Mübeccel Akdis, MD, and Cezmi A. Akdis, MD |
| 264 | 1 | |c February 2016 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 29.01.2019 | ||
| 520 | |a This article continues the comprehensive international consensus (ICON) statement on allergen immunotherapy (AIT). The initial article also recently appeared in the Journal. The conclusions below focus on key mechanisms of AIT-triggered tolerance, requirements in allergen standardization, AIT cost-effectiveness, and regulatory guidance. Potential barriers to and facilitators of the use of AIT are described in addition to future directions. International allergy specialists representing the European Academy of Allergy and Clinical Immunology; the American Academy of Allergy, Asthma & Immunology; the American College of Allergy, Asthma and Immunology; and the World Allergy Organization critically reviewed the existing literature and prepared this summary of recommendations for best AIT practice. The authors contributed equally and reached consensus on the statements presented herein. | ||
| 650 | 4 | |a allergen standardization | |
| 650 | 4 | |a allergen vaccine | |
| 650 | 4 | |a allergy | |
| 650 | 4 | |a cost-effectiveness | |
| 650 | 4 | |a immunotherapy | |
| 650 | 4 | |a International consensus | |
| 650 | 4 | |a marketing authorization | |
| 650 | 4 | |a mechanisms | |
| 650 | 4 | |a pharmacoeconomics | |
| 650 | 4 | |a regulatory authorities | |
| 650 | 4 | |a tolerance | |
| 650 | 4 | |a unmet needs | |
| 700 | 1 | |a Pfaar, Oliver |d 1972- |e VerfasserIn |0 (DE-588)12385900X |0 (DE-627)706454049 |0 (DE-576)293913099 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The journal of allergy and clinical immunology |d Amsterdam [u.a.] : Elsevier, 1971 |g 137(2016), 2, Seite 358-368 |h Online-Ressource |w (DE-627)32045553X |w (DE-600)2006613-2 |w (DE-576)094478864 |x 1097-6825 |7 nnas |a International consensus on allergen immunotherapy II mechanisms, standardization, and pharmacoeconomics |
| 773 | 1 | 8 | |g volume:137 |g year:2016 |g number:2 |g pages:358-368 |g extent:11 |a International consensus on allergen immunotherapy II mechanisms, standardization, and pharmacoeconomics |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jaci.2015.12.1300 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0091674915031140 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190129 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 12385900X |a Pfaar, Oliver |m 12385900X:Pfaar, Oliver |d 60000 |d 62100 |e 60000PP12385900X |e 62100PP12385900X |k 0/60000/ |k 1/60000/62100/ |p 19 | ||
| 999 | |a KXP-PPN1586719149 |e 3049970170 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"eki":["1586719149"],"doi":["10.1016/j.jaci.2015.12.1300"]},"origin":[{"dateIssuedDisp":"February 2016","dateIssuedKey":"2016"}],"name":{"displayForm":["Marek Jutel, MD, Ioana Agache, MD, Sergio Bonini, MD, A. Wesley Burks, MD, Moises Calderon, MD, Walter Canonica, MD, Linda Cox, MD, Pascal Demoly, MD, Antony J. Frew, MD, FRCP, Robyn O’Hehir, FRACP, PhD, Jörg Kleine-Tebbe, MD, Antonella Muraro, MD, PhD, Gideon Lack, MD, Désirée Larenas, MD, Michael Levin, MD, Bryan L. Martin, MD, Harald Nelson, MD, Ruby Pawankar, MD, Oliver Pfaar, MD, Ronald van Ree, PhD, Hugh Sampson, MD, James L. Sublett, MD, Kazunari Sugita, MD, George Du Toit, MD, Thomas Werfel, MD, Roy Gerth van Wijk, MD, Luo Zhang, MD, Mübeccel Akdis, MD, and Cezmi A. Akdis, MD"]},"relHost":[{"title":[{"subtitle":"official publication of the American Academy of Allergy, Asthma and Immunology","title":"The journal of allergy and clinical immunology","title_sort":"journal of allergy and clinical immunology"}],"part":{"year":"2016","issue":"2","pages":"358-368","text":"137(2016), 2, Seite 358-368","volume":"137","extent":"11"},"pubHistory":["47.1971 -"],"language":["eng"],"recId":"32045553X","note":["Gesehen am 23.08.2021"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"International consensus on allergen immunotherapy II mechanisms, standardization, and pharmacoeconomicsThe journal of allergy and clinical immunology","id":{"issn":["1097-6825"],"eki":["32045553X"],"zdb":["2006613-2"]},"origin":[{"dateIssuedDisp":"1971-","dateIssuedKey":"1971","publisher":"Elsevier ; Mosby","publisherPlace":"Amsterdam [u.a.] ; St. Louis, Mo."}],"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"11 S."}],"title":[{"title_sort":"International consensus on allergen immunotherapy II","subtitle":"mechanisms, standardization, and pharmacoeconomics","title":"International consensus on allergen immunotherapy II"}],"person":[{"given":"Marek","family":"Jutel","role":"aut","roleDisplay":"VerfasserIn","display":"Jutel, Marek"},{"family":"Pfaar","given":"Oliver","display":"Pfaar, Oliver","roleDisplay":"VerfasserIn","role":"aut"}],"language":["eng"],"recId":"1586719149","type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 29.01.2019"]} | ||
| SRT | |a JUTELMAREKINTERNATIO2016 | ||